Effects of triethylene tetraamine on telomerase activity and proliferation in HeLa cells

Cell Biology International

Volumn 28, Issue 4, 2004, Pages 287-291

  Yin, Fei ^a   Liu, Jianhui ^b   Peng, Xiaojun ^a  

^a DALIAN UNIVERSITY OF TECHNOLOGY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Cell cycle; Proliferation; Telomerase; Triethylene tetraamine

Indexed keywords

CELL EXTRACT; TELOMERASE; TRIENTINE;

ARTICLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; FLOW CYTOMETRY; HELA CELL; HUMAN; HUMAN CELL; IC 50; TELOMERIC REPEAT AMPLIFICATION PROTOCOL;

CELL CYCLE; ENZYME ACTIVATION; G1 PHASE; HELA CELLS; HUMANS; TELOMERASE; TRIETHYLENETETRAMINE;

EID: 1942421651     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2004.01.001     Document Type: Article

References (18)

1. Akiyama M., Yamada-Horiguchi J., Saito S., Hoshi Y., Yamada O., Mizoguchi H., et al. Cytostatic concentrations of anticancer agents do not affect telomerase activity of leukemic cells in vitro. Eur J Cancer. 35:(2):1999;309-315.
2. Albanell J., Han W., Mellado B., Gunawardane R., Scher H.I., Dmitrovosky E., et al. Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines. Cancer Res. 56:1996;1503-1508.
3. Bestilny L.J., Brown C.B., Miura Y., Robertson L.D., Riabowol K.T. Inhibition of telomerase activity during terminal differentiation of immortal cell lines. Cancer Res. 56:1996;3796-3802.
4. Bryan T.M., Engelzou A., Gupta J., Bachetti S., Reddel R.R. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J. 14:1995;4240-4248.
5. Hahn W.C., Counter C.M., Lundberg A.S., Beijersbergen R.L., Brooks M.W., Weinberg R.A. Creation of human tumour cells with defined genetic elements. Nature. 400:(6743):1999;464-468.
6. Herbert B.S., Pongracz K., Shay J.W., Gryaznov S.M. Oligonucleotide N3′→P5′ phosphoramidates as efficient telomerase inhibitors. Oncogene. 21:(4):2002;638-642.
7. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L.C., et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 266:(5193):1994;2011-2015.
8. Levy M.Z., Allsopp R.C., Futcher A.B., Greider C.W., Harlery C.B. Telomere end-replication problem and cell aging. J Mol Biol. 225:1992;951-960.
9. Ludwig A., Saretzki G., Holm P.S., Tiemann F., Lorenz M., Emrich T., et al. Ribozyme cleavage of telomerase mRNA sensitizes breastepithelial cells to inhibitors of topoisomerase. Cancer Res. 61:(7):2001;3053-3061.
10. Nakamura T.M., Morin G.B., Chapman K.B., Weinrich S.L., Andrews W.H., Lingner J., et al. Telomerase catalytic subunit homologs from fission yeast and human. Science. 277:(5328):1997;955-959.
11. Hansen M.B., Nielson S.E., Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods. 119:1989;302-310.
12. Holt S.E., Wright W.E., Shay J.W. Regulation of telomerase activity in immortal cell lines. Mol Cell Biol. 16:1996;2932-2939.
13. Parkinson G.N., Lee M.P.H., Neidle S. Crystal structure of parallel quadruplexes from human telomeric DNA. Nature. 417:(6891):2002;876-880.
14. Pitts A.E., Corey D.R. The telomerase challenge - an unusual problem in drug discovery. Drug Discov Today. 4:1999;155-161.
15. Sharma H.W., Sokoloski J.S., Perez J.R., Maltese J.Y., Sartorelli A.C., Stein C.A., et al. Differentiation of immortal cells inhibits telomerase activity. Proc Natl Acad Sci U S A. 92:1996;12343-12346.
16. Wright W.E., Piatysek M.A., Rainey W.E., Byrd W., Shay J.W. Telomerase activity in human germ line and embryonic tissues and cells. Dev Genet. 18:1996;173-179.
17. Yin F., Liu J.H., Peng X.J. Triethylene tetraamine: A novel telomerase inhibitor. Bioorg Med Chem Lett. 22:(13):2003;3293-3296.
18. Zhang J.D., Reedy M.C., Hannun Y.A., Obeid L.M. Inhibition of caspases inhibits the release of apoptotic bodies: Bcl-2 inhibits the initiation of formation of apoptotic bodies in chemotherapeutic agent-induced apoptosis. J Cell Biol. 145:1999;99-108.